Publications
Detailed Information
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent-3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial -
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Chee Hae | - |
dc.contributor.author | Park, Kyung Woo | - |
dc.contributor.author | Kang, Jeehoon | - |
dc.contributor.author | Park, Byoung-Eun | - |
dc.contributor.author | Cha, Kwang Soo | - |
dc.contributor.author | Rhew, Jay Young | - |
dc.contributor.author | Jeon, Hui-Kyung | - |
dc.contributor.author | Shin, Eun-Seok | - |
dc.contributor.author | Oh, Ju Hyeon | - |
dc.contributor.author | Jeong, Myung-Ho | - |
dc.contributor.author | Kim, Sanghyun | - |
dc.contributor.author | Hwang, Kyung-Kuk | - |
dc.contributor.author | Yoon, Jung-Han | - |
dc.contributor.author | Lee, Sung Yun | - |
dc.contributor.author | Park, Tae-Ho | - |
dc.contributor.author | Moon, Keon Woong | - |
dc.contributor.author | Kwon, Hyuck-Moon | - |
dc.contributor.author | Hur, Seung-Ho | - |
dc.contributor.author | Ryu, Jae-Kean | - |
dc.contributor.author | Lee, Bong-Ryul | - |
dc.contributor.author | Park, Yong Whi | - |
dc.contributor.author | Chae, In-Ho | - |
dc.contributor.author | Kim, Hyo-Soo | - |
dc.date.accessioned | 2023-04-19T00:59:41Z | - |
dc.date.available | 2023-04-19T00:59:41Z | - |
dc.date.created | 2020-04-02 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.citation | Circulation Journal, Vol.83 No.7, pp.1489-1497 | - |
dc.identifier.issn | 1346-9843 | - |
dc.identifier.uri | https://hdl.handle.net/10371/190339 | - |
dc.description.abstract | Background: There are limited data on the long-term outcome of platinum chromium-based everolimus-eluting stents (PtCr-EES) vs. cobalt chromium-based zotarolimus-eluting stents (CoCr-ZES). Methods and Results: A total of 3,755 patients undergoing percutaneous coronary intervention (PCI) were randomized 2: 1 to PtCr-EES or CoCr-ZES, and 96.0% of patients completed the 3-year clinical follow-up. The primary outcome was target lesion failure (TLF), defined as a composite of cardiac death, target vessel-related myocardial infarction (MI), and clinically-driven target lesion revascularization (TLR). At 3 years, TLF occurred in 5.3% and in 5.4% of the PtCr-EES and CoCr-ZES groups, respectively (hazard ratio 0.978; 95% confidence interval 0.730-1.310, P=0.919). There were no significant differences in the individual components of TLF. Routine angiographic follow-up was performed in 38.9% of the total patients. In a landmark analysis of the subgroup that had follow-up angiography, the clinically-driven TLR rate of CoCr-ZES was significantly higher than PtCr-EES group during the angiography follow-up period (P=0.009). Overall definite and probable stent thrombosis rates were very low in both groups (0.5% vs. 0.6%, P=0.677). Conclusions: PtCr-EES and CoCr-ZES had similar and excellent long-term outcomes in both efficacy and safety after PCI in an all-comer population. | - |
dc.language | 영어 | - |
dc.publisher | Japanese Circulation Society/Nihon Junkanki Gakkai | - |
dc.title | Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent-3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial - | - |
dc.type | Article | - |
dc.identifier.doi | 10.1253/circj.CJ-18-1303 | - |
dc.citation.journaltitle | Circulation Journal | - |
dc.identifier.wosid | 000473549900012 | - |
dc.identifier.scopusid | 2-s2.0-85068624365 | - |
dc.citation.endpage | 1497 | - |
dc.citation.number | 7 | - |
dc.citation.startpage | 1489 | - |
dc.citation.volume | 83 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Kim, Sanghyun | - |
dc.contributor.affiliatedAuthor | Chae, In-Ho | - |
dc.contributor.affiliatedAuthor | Kim, Hyo-Soo | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | DUAL ANTIPLATELET THERAPY | - |
dc.subject.keywordPlus | BARE-METAL STENTS | - |
dc.subject.keywordPlus | BIODEGRADABLE-POLYMER | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | RESOLUTE | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordAuthor | Clinical outcome | - |
dc.subject.keywordAuthor | Cobalt chromium-based zotarolimus-eluting stent | - |
dc.subject.keywordAuthor | Drug-eluting stent | - |
dc.subject.keywordAuthor | Percutaneous coronary intervention | - |
dc.subject.keywordAuthor | Platinum chromium-based everolimus-eluting stent | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.